Indeed, evidence suggests that augmenting insulin receptor signaling by direct stimulation of the insulin receptor pathway by insulin and also indirect positive modulation of the pathway by other factors, including incretins and APN, may be effective against neurodegenerative disease (Fig. 3a). This evidence concerns the gene INSR and neurodegenerative disease.